COGT logo

COGT
Cogent Biosciences Inc

3,168
Mkt Cap
$6.31B
Volume
1.2M
52W High
$43.73
52W Low
$3.72
PE Ratio
-15.18
COGT Fundamentals
Price
$38.89
Prev Close
$38.85
Open
$38.10
50D MA
$37.68
Beta
1.56
Avg. Volume
2.44M
EPS (Annual)
-$2.55
P/B
11.44
Rev/Employee
$0.00
$4,008.57
Loading...
Loading...
News
all
press releases
Cogent Biosciences, Inc. $COGT Stock Position Cut by NEOS Investment Management LLC
NEOS Investment Management LLC decreased its stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 23.6% during the 3rd quarter, according to the company in its most recent 13F...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
Readystate Asset Management LP Takes $714,000 Position in Cogent Biosciences, Inc. $COGT
Readystate Asset Management LP bought a new position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the third quarter, according to its most recent filing with the Securities and...
MarketBeat·11d ago
News Placeholder
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Recommendation of "Moderate Buy" from Analysts
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the fifteen brokerages that are covering the stock, Marketbeat Ratings reports...
MarketBeat·13d ago
News Placeholder
Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million
Key PointsRock Springs Capital Management sold 159,278 shares of Cogent Biosciences in the fourth quarter; the estimated trade size was $4.48 million based on quarterly average prices...
Nasdaq News: Markets·13d ago
News Placeholder
Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough
Key PointsFirst Turn Management acquired 824,283 shares of Cogent Biosciences in the fourth quarter...
Nasdaq News: Markets·13d ago
News Placeholder
Cogent Biosciences (NASDAQ:COGT) Posts Earnings Results, Misses Estimates By $0.22 EPS
Cogent Biosciences (NASDAQ:COGT - Get Free Report) announced its earnings results on Tuesday. The technology company reported ($0.73) earnings per share (EPS) for the quarter, missing the consensus...
MarketBeat·13d ago
News Placeholder
Cogent Biosciences (COGT) to Release Quarterly Earnings on Tuesday
Cogent Biosciences (NASDAQ:COGT) will be releasing its Q4 2025 earnings before the market opens on Tuesday, February 24. (View Earnings Report at...
MarketBeat·14d ago
News Placeholder
272,460 Shares in Cogent Biosciences, Inc. $COGT Acquired by Principal Financial Group Inc.
Principal Financial Group Inc. purchased a new stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the third quarter, according to its most recent disclosure with the...
MarketBeat·15d ago
News Placeholder
Cogent Biosciences, Inc. $COGT Shares Bought by Candriam S.C.A.
Candriam S.C.A. lifted its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 123.3% during the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·20d ago
News Placeholder
Federated Hermes Inc. Purchases 93,223 Shares of Cogent Biosciences, Inc. $COGT
Federated Hermes Inc. grew its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 4,661,150.0% in the third quarter, according to the company in its most recent 13F filing...
MarketBeat·25d ago
<
1
2
...
>

Latest COGT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.